We are live on ! Find out more
PG

PEAK6 Group Portfolio holdings

AUM $23.4B
1-Year Est. Return 17.65%
This Fund
S&P 500
This Quarter Est. Return
-11.18%
1 Year Est. Return
+17.65%
3 Year Est. Return
+39.88%
5 Year Est. Return
+85.2%
10 Year Est. Return
–
AUM
$19.1B
AUM Growth
+$2.25B
Cap. Flow
+$4.38B
Cap. Flow %
23%
Top 10 Hldgs %
6.59%
Holding
6,124
New
1,182
Increased
2,113
Reduced
1,642
Closed
1,063

Top Buys

Rank Stock Value
1
FDX icon
FedEx
FDX
+$49.5M
2
GILD icon
Gilead Sciences
GILD
+$33M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$31.8M
4
BIIB icon
Biogen
BIIB
+$31.3M
5
ILMN icon
Illumina
ILMN
+$25.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$40M
2
SBUX icon
Starbucks
SBUX
+$31.6M
3
NKE icon
Nike
NKE
+$29.1M
4
YUM icon
Yum! Brands
YUM
+$25.9M
5
BABA icon
Alibaba
BABA
+$24.9M

Sector Composition

Rank Sector Weight
1 Healthcare 2.57%
2 Consumer Discretionary 1.99%
3 Industrials 1.87%
4 Financials 1.8%
5 Technology 1.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AER icon
426
CALL
AerCap
AER
$23.9B
$11.1M 0.06%
290,600
-163,900
-36% -$7.24M
PII icon
427
PUT
Polaris
PII
$4.15B
$11.1M 0.06%
92,700
+11,500
+14% +$1.56M
CSCO icon
428
CALL
Cisco
CSCO
$450B
$11M 0.06%
419,100
+125,100
+43% +$3.38M
TARO
429
PUT
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$11M 0.06%
76,900
+36,100
+88% +$5.05M
UNP icon
430
PUT
Union Pacific
UNP
$182B
$11M 0.06%
123,900
+37,600
+44% +$3.43M
BMY icon
431
PUT
Bristol-Myers Squibb
BMY
$127B
$10.9M 0.06%
184,400
+20,200
+12% +$1.28M
TFC icon
432
CALL
Truist Financial
TFC
$63.2B
$10.9M 0.06%
306,400
+176,600
+136% +$6.81M
VXX
433
PUT
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$10.9M 0.06%
26,563
+20,313
+325% +$6.76M
P
434
PUT
DELISTED
Pandora Media Inc
P
$10.9M 0.06%
509,700
-245,200
-32% -$4.3M
BA icon
435
Boeing
BA
$165B
$10.8M 0.06%
82,818
+36,748
+80% +$5.1M
PAYX icon
436
CALL
Paychex
PAYX
$40.4B
$10.8M 0.06%
226,900
+129,400
+133% +$6.03M
RTN
437
PUT
DELISTED
Raytheon Company
RTN
$10.8M 0.06%
98,700
+52,600
+114% +$5.5M
LRCX icon
438
CALL
Lam Research
LRCX
$382B
$10.8M 0.06%
1,649,000
+742,000
+82% +$5.44M
MYGN icon
439
CALL
Myriad Genetics
MYGN
$530M
$10.8M 0.06%
287,400
+260,200
+957% +$9.23M
IBB icon
440
PUT
iShares Biotechnology ETF
IBB
$9.31B
$10.7M 0.06%
105,900
+52,800
+99% +$6.33M
LNKD
441
DELISTED
LinkedIn Corporation
LNKD
$10.7M 0.06%
56,076
-45,160
-45% -$8.97M
IBB icon
442
iShares Biotechnology ETF
IBB
$9.31B
$10.6M 0.06%
105,006
+64,857
+162% +$7.78M
AZN icon
443
AstraZeneca
AZN
$263B
$10.6M 0.06%
166,379
+85,850
+107% +$5.65M
AZO icon
444
PUT
AutoZone
AZO
$48.3B
$10.6M 0.06%
14,600
+10,900
+295% +$7.72M
VRTX icon
445
PUT
Vertex Pharmaceuticals
VRTX
$121B
$10.6M 0.06%
101,400
+27,900
+38% +$3.58M
EEM icon
446
iShares MSCI Emerging Markets ETF
EEM
$28B
$10.6M 0.06%
+321,845
New +$11.4M
EDU icon
447
PUT
New Oriental
EDU
$7.84B
$10.5M 0.06%
521,300
+1,700
+0.3% +$36.4K
JOYY
448
JOYY Inc
JOYY
$3.73B
$10.5M 0.06%
192,750
+144,028
+296% +$8.31M
CME icon
449
CALL
CME Group
CME
$92.2B
$10.5M 0.06%
113,300
+26,400
+30% +$2.51M
BBBY
450
CALL
DELISTED
Bed Bath & Beyond Inc
BBBY
$10.5M 0.06%
184,200
-30,000
-14% -$1.91M
16 17
18
19 20

Similar funds

FEF
Fundsmith Equity Fund Stamford, Connecticut $13.4B AUM
HIM
Hermes Investment Management London Uk, United Kingdom $7.52B AUM 20.67% 1-Year Est. Return
GXMC
Global X Management Company New York $5.62B AUM 10.7% 1-Year Est. Return
IAMU
Impax Asset Management (UK) London, United Kingdom $4.12B AUM 10.79% 1-Year Est. Return
IAM
Impax Asset Management Portsmouth, New Hampshire $1.69B AUM 16.26% 1-Year Est. Return
EA
Edge Advisors Atlanta, Georgia $1.12B AUM 9.47% 1-Year Est. Return
OMCS
Old Mutual Customised Solutions Pinelands, South Africa $1B AUM 15.88% 1-Year Est. Return
TPCM
Tide Point Capital Management Old Greenwich, Connecticut $851M AUM 25.25% 1-Year Est. Return

PEAK6 Group's Q3 2015 Portfolio in Review

As of Q3 2015, PEAK6 Group held 6,124 positions worth $19.1B, up 13% from $16.8B the previous quarter. Its ten largest holdings account for 6.6% of the portfolio.

PEAK6 Group deployed $4.38B of net new capital in Q3 2015, opening 1,182 new positions and adding to 2,113 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 59,241 shares worth $27.6M.

By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, up from 1.6% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Apple, an estimated $40M trimmed.

  • PEAK6 Group's largest Q3 2015 buy was Regeneron Pharmaceuticals: 59,241 shares worth $27.6M.
  • PEAK6 Group added most to FedEx in Q3 2015, an estimated $49.5M increase.
  • PEAK6 Group's biggest Q3 2015 reduction was Apple, cutting an estimated $40M.
  • PEAK6 Group fully exited Nike in Q3 2015, selling an estimated $29.1M.
  • PEAK6 Group's ten largest holdings make up 6.6% of its $19.1B portfolio in Q3 2015.
  • PEAK6 Group opened 1,182 new positions and closed 1,063 in Q3 2015.
  • PEAK6 Group's portfolio value rose 13% quarter-over-quarter to $19.1B.

Based on PEAK6 Group's 13F filing for Q3 2015, filed 16 Nov 2015.